Recently, Sun Pharma has also acquired Concert, a US-based pharmaceuticals firm, in January. The Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. On Friday, the ...
Drug major Sun Pharmaceutical on Friday announced that it is set to acquire 60 per cent shareholding in Vivaldis Health & Foods for ₹143.30 crore from its existing shareholders, The remaining 40 per ...
Sun Pharmaceuticals Limited on March 4 announced that it is set to acquire 60% shareholding in Vivaldis Health & Foods for Rs 143.30 crore from its existing shareholders. The company is engaged in the ...
Come for the presents. Stay for the baggage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback